An Observational Study to Learn More About the Use of Vericiguat in Korean People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in Real-world Setting

Conditions: Chronic Heart Failure With Reduced Ejection Fraction Interventions: Drug: Vericiguat (Verquvo, BAY1021189) Sponsors: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials